SERSTECH AB: Notice of Annual General Meeting in Serstech AB (publ.)
29 mars 2021 12h16 HE
|
Serstech
This notice is published in both the Swedish and the English language. In the event of inconsistency or discrepancy between the English version and the Swedish version of this publication, the Swedish...
SERSTECH AB: Serstech genomför en företrädesemission om 25MSEK
29 mars 2021 12h15 HE
|
SERSTECH AB
Serstech har under de tre senaste åren byggt upp och förfinat en välfungerande intern organisation och ett globalt distributionsnätverk, som idag består av 90 partners. Den kommersiella grunden lades...
SERSTECH AB: Serstech announces a rights issue of 25MSEK
29 mars 2021 12h15 HE
|
Serstech
This announcement is published in both the Swedish and the English language. In the event of inconsistency or discrepancy between the English version and the Swedish version of this...
Allarity Therapeutics plans fully guaranteed rights issue of approximately SEK 100 million
23 mars 2021 03h30 HE
|
Allarity Therapeutics A/S
- Proceeds will finance further development of three high-priority programs- Rights Issue is fully covered by subscription undertakings and guarantee commitments - The Company will discontinue the use...
Aedifica NV/SA: Admission to trading of new shares on the regulated market of Euronext Brussels and Euronext Amsterdam
27 oct. 2020 03h08 HE
|
Aedifica
Please find below a press release issued by Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the admission to trading...
Aedifica NV/SA: Capital increase – final results
23 oct. 2020 09h30 HE
|
Aedifica
Please find below a press release issued by Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the final results of the...
Aedifica NV/SA: Capital increase – preliminary results
23 oct. 2020 04h16 HE
|
Aedifica
Please find below a press release issued by Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the preliminary results...
Rights issue oversubscribed
18 déc. 2019 02h45 HE
|
SERSTECH AB
On December 12, 2019, the subscription period ended in Serstech AB´s (“Serstech”) rights issue. The rights issue was subscribed for a total of approx. SEK 32.9 million (excl. guarantee commitments),...
Nexstim Abp: Förändring av warrantvillkoren
23 mai 2019 11h30 HE
|
Nexstim Oyj
Pressmeddelande, Helsingfors, 23 maj 2019 kl. 18.30 Nexstim Abp: Förändring av warrantvillkoren Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”Bolaget”), ett företag inom riktad...
Nexstim Oyj: Warrant-ehtojen muuttaminen
23 mai 2019 11h30 HE
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 23.5.2019 klo 18.30 Nexstim Oyj: Warrant-ehtojen muuttaminen Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”), neuromodulaatioyritys, joka on kehittänyt...